Alpha conotoxin precursor |
α-Conotoxin PnIB from C. pennaceus, disulfide bonds shown in yellow. From the University of Michigan's Orientations of Proteins in Membranes database, PDB 1AKG.
|
Identifiers |
Symbol |
Toxin_8 |
Pfam |
PF07365 |
InterPro |
IPR009958 |
PROSITE |
PDOC60004 |
SCOP |
1mii |
SUPERFAMILY |
1mii |
OPM superfamily |
157 |
OPM protein |
1akg |
Available protein structures: |
Pfam |
structures |
PDB |
RCSB PDB; PDBe; PDBj |
PDBsum |
structure summary |
|
Omega conotoxin |
Schematic diagram of the three-dimensional structure of ω-conotoxin MVIIA (ziconotide). Disulfide bonds are shown in gold. From PDB 1DW5.
|
Identifiers |
Symbol |
Conotoxin |
Pfam |
PF02950 |
InterPro |
IPR004214 |
SCOP |
2cco |
SUPERFAMILY |
2cco |
OPM superfamily |
120 |
OPM protein |
1fyg |
Available protein structures: |
Pfam |
structures |
PDB |
RCSB PDB; PDBe; PDBj |
PDBsum |
structure summary |
|
A conotoxin is one of a group of neurotoxic peptides isolated from the venom of the marine cone snail, genus Conus.
Conotoxins, which are peptides consisting of 10 to 30 amino acid residues, typically have one or more disulfide bonds. Conotoxins have a variety of mechanisms of actions, most of which have not been determined. However, it appears that many of these peptides modulate the activity of ion channels.[1] Over the last few decades conotoxins have been subject of pharmacological interest.[2]
Contents
- 1 Hypervariability
- 2 Disulfide connectivities
- 3 Types and biological activities
- 3.1 Alpha
- 3.2 Delta and kappa, and omega
- 3.3 Mu
- 4 See also
- 5 References
- 6 External links
Hypervariability[edit]
Conotoxins are hypervariable even within the same species; the genes that encode them act endogenously,[3] and thus are less conserved and more likely to experience gene duplication events and nonsynonymous mutations which lead to the development of novel functions.[4] These genes will experience less selection against mutations, and therefore mutations will remain in the genome longer, allowing more time for potentially beneficial novel functions to arise.[5] Variability in conotoxin components reduces the likelihood that prey organisms will develop resistance; thus cone snails are under constant selective pressure to maintain polymorphism in these genes because failing to evolve and adapt will lead to extinction (Red Queen Hypothesis).[6]
Disulfide connectivities[edit]
Types of conotoxins also differ in the number and pattern of disulfide bonds.[7] The disulfide bonding network, as well as specific amino acids in inter-cysteine loops, provide the specificity of conotoxins.[8]
Types and biological activities[edit]
The number of conotoxins whose activities have been determined so far is five, and they are called the α(alpha)-, δ(delta)-, κ(kappa)-, μ(mu)-, and ω(omega)- types. Each of the five types of conotoxins attacks a different target:
- α-conotoxin inhibits nicotinic acetylcholine receptors at nerves and muscles.[9]
- δ-conotoxin inhibits the inactivation of voltage-dependent sodium channels.[10]
- κ-conotoxin inhibits potassium channels.[11]
- μ-conotoxin inhibits voltage-dependent sodium channels in muscles.[12]
- ω-conotoxin inhibits N-type voltage-dependent calcium channels.[13] Because N-type voltage-dependent calcium channels are related to algesia (sensitivity to pain) in the nervous system, ω-conotoxin has an analgesic effect: the effect of ω-conotoxin M VII A is 100 to 1000 times that of morphine.[14] Therefore a synthetic version of ω-conotoxin M VII A has found application as an analgesic drug ziconotide (Prialt).[15]
Alpha[edit]
Alpha conotoxins have two types of cysteine arrangements,[16] and are competitive nicotinic acetylcholine receptor antagonists.
Delta and kappa, and omega[edit]
Omega, delta and kappa families of conotoxins have a knottin or inhibitor cysteine knot scaffold. The knottin scaffold is a very special disulfide-through-disulfide knot, in which the III-VI disulfide bond crosses the macrocycle formed by two other disulfide bonds (I-IV and II-V) and the interconnecting backbone segments, where I-VI indicates the six cysteine residues starting from the N-terminus. The cysteine arrangements are the same for omega, delta and kappa families, even though omega conotoxins are calcium channel blockers, whereas delta conotoxins delay the inactivation of sodium channels, and kappa conotoxins are potassium channel blockers.[7]
Mu[edit]
Mu-conotoxin |
nmr solution structure of piiia toxin, nmr, 20 structures
|
Identifiers |
Symbol |
Mu-conotoxin |
Pfam |
PF05374 |
Pfam clan |
CL0083 |
InterPro |
IPR008036 |
SCOP |
1gib |
SUPERFAMILY |
1gib |
OPM superfamily |
120 |
OPM protein |
1ag7 |
Available protein structures: |
Pfam |
structures |
PDB |
RCSB PDB; PDBe; PDBj |
PDBsum |
structure summary |
|
Mu-conotoxins have two types of cysteine arrangements, but the knottin scaffold is not observed.[17] Mu-conotoxins target the muscle-specific voltage-gated sodium channels,[7] and are useful probes for investigating voltage-dependent sodium channels of excitable tissues.[17][18] Mu-conotoxins target the voltage-gated sodium channels, preferentially those of skeletal muscle,[19] and are useful probes for investigating voltage-dependent sodium channels of excitable tissues.[20]
Different subtypes of voltage-gated sodium channels are found in different tissues in mammals, e.g., in muscle and brain, and studies have been carried out to determine the sensitivity and specificity of the mu-conotoxins for the different isoforms.[21]
See also[edit]
References[edit]
- ^ Terlau H, Olivera BM (2004). "Conus venoms: a rich source of novel ion channel-targeted peptides". Physiol. Rev. 84 (1): 41–68. doi:10.1152/physrev.00020.2003. PMID 14715910.
- ^ Olivera BM, Teichert RW (2007). "Diversity of the neurotoxic Conus peptides: a model for concerted pharmacological discovery.". Mol Interv 7 (5): 251–60. doi:10.1124/mi.7.5.7. PMID 17932414.
- ^ Biggs JS, Watkins M, Puillandre N, Ownby JP, Lopez-Vera E, Christensen S, Moreno KJ, Bernaldez J, Licea-Navarro A, Corneli PS, Olivera BM (July 2010). "Evolution of Conus peptide toxins: analysis of Conus californicus Reeve, 1844". Mol. Phylogenet. Evol. 56 (1): 1–12. doi:10.1016/j.ympev.2010.03.029. PMC 3488448. PMID 20363338.
- ^ Olivera BM, Watkins M, Bandyopadhyay P, Imperial JS, de la Cotera EP, Aguilar MB, Vera EL, Concepcion GP, Lluisma A (September 2012). "Adaptive radiation of venomous marine snail lineages and the accelerated evolution of venom peptide genes". Ann. N. Y. Acad. Sci. 1267: 61–70. doi:10.1111/j.1749-6632.2012.06603.x. PMC 3488454. PMID 22954218.
- ^ Wong ES, Belov K (March 2012). "Venom evolution through gene duplications". Gene 496 (1): 1–7. doi:10.1016/j.gene.2012.01.009. PMID 22285376.
- ^ Liow LH, Van Valen L, Stenseth NC (July 2011). "Red Queen: from populations to taxa and communities". Trends Ecol. Evol. (Amst.) 26 (7): 349–58. doi:10.1016/j.tree.2011.03.016. PMID 21511358.
- ^ a b c Jones RM, McIntosh JM (2001). "Cone venom--from accidental stings to deliberate injection". Toxicon 39 (10): 1447–1451. doi:10.1016/S0041-0101(01)00145-3. PMID 11478951.
- ^ Sato K, Kini RM, Gopalakrishnakone P, Balaji RA, Ohtake A, Seow KT, Bay BH (2000). "lambda-conotoxins, a new family of conotoxins with unique disulfide pattern and protein folding. Isolation and characterization from the venom of Conus marmoreus". J. Biol. Chem. 275 (50): 39516–39522. doi:10.1074/jbc.M006354200. PMID 10988292.
- ^ Nicke A, Wonnacott S, Lewis RJ (2004). "Alpha-conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypes". Eur. J. Biochem. 271 (12): 2305–2319. doi:10.1111/j.1432-1033.2004.04145.x. PMID 15182346.
- ^ Leipold E, Hansel A, Olivera BM, Terlau H, Heinemann SH (2005). "Molecular interaction of delta-conotoxins with voltage-gated sodium channels". FEBS Lett. 579 (18): 3881–3884. doi:10.1016/j.febslet.2005.05.077. PMID 15990094.
- ^ Shon KJ, Stocker M, Terlau H, Stühmer W, Jacobsen R, Walker C, Grilley M, Watkins M, Hillyard DR, Gray WR, Olivera BM (1998). "kappa-Conotoxin PVIIA is a peptide inhibiting the shaker K+ channel". J. Biol. Chem. 273 (1): 33–38. doi:10.1074/jbc.273.1.33. PMID 9417043.
- ^ Li RA, Tomaselli GF (2004). "Using the deadly mu-conotoxins as probes of voltage-gated sodium channels". Toxicon 44 (2): 117–122. doi:10.1016/j.toxicon.2004.03.028. PMC 2698010. PMID 15246758.
- ^ Nielsen KJ, Schroeder T, Lewis R (2000). "Structure-activity relationships of omega-conotoxins at N-type voltage-sensitive calcium channels" (abstract). J. Mol. Recognit. 13 (2): 55–70. doi:10.1002/(SICI)1099-1352(200003/04)13:2<55::AID-JMR488>3.0.CO;2-O. PMID 10822250.
- ^ Bowersox SS, Luther R (1998). "Pharmacotherapeutic potential of omega-conotoxin MVIIA (SNX-111), an N-type neuronal calcium channel blocker found in the venom of Conus magus". Toxicon 36 (11): 1651–1658. doi:10.1016/S0041-0101(98)00158-5. PMID 9792182.
- ^ Prommer E (2006). "Ziconotide: a new option for refractory pain". Drugs Today 42 (6): 369–78. doi:10.1358/dot.2006.42.6.973534. PMID 16845440.
- ^ Gray WR, Olivera BM, Zafaralla GC, Ramilo CA, Yoshikami D, Nadasdi L, Hammerland LG, Kristipati R, Ramachandran J, Miljanich G (1992). "Novel alpha- and omega-conotoxins from Conus striatus venom". Biochemistry 31 (41): 11864–11873. doi:10.1021/bi00162a027. PMID 1390774.
- ^ a b Nielsen KJ, Watson M, Adams DJ, Hammarström AK, Gage PW, Hill JM, Craik DJ, Thomas L, Adams D, Alewood PF, Lewis RJ (July 2002). J. Biol. Chem. 277 (30): 27247–55. doi:10.1074/jbc.M201611200. PMID 12006587.
- ^ Zeikus RD, Gray WR, Cruz LJ, Olivera BM, Kerr L, Moczydlowski E, Yoshikami D (1985). "Conus geographus toxins that discriminate between neuronal and muscle sodium channels". J. Biol. Chem. 260 (16): 9280–8. PMID 2410412.
- ^ McIntosh JM, Jones RM (October 2001). "Cone venom--from accidental stings to deliberate injection". Toxicon 39 (10): 1447–51. doi:10.1016/S0041-0101(01)00145-3. PMID 11478951.
- ^ Cruz LJ, Gray WR, Olivera BM, Zeikus RD, Kerr L, Yoshikami D, Moczydlowski E (August 1985). "Conus geographus toxins that discriminate between neuronal and muscle sodium channels". J. Biol. Chem. 260 (16): 9280–8. PMID 2410412.
- ^ Floresca CZ (2003). "A comparison of the mu-conotoxins by [3H]saxitoxin binding assays in neuronal and skeletal muscle sodium channel.". Toxicol Appl Pharmacol 190 (2): 95–101. PMID 12878039.
External links[edit]
- Conotoxins at the US National Library of Medicine Medical Subject Headings (MeSH)
- Baldomero "Toto" Olivera's short talk:. "Conus Peptides".
- Kaas Q, Westermann JC, Halai R, Wang CK, Craik DJ. "ConoServer". Institute of Molecular Bioscience, The University of Queensland, Australia. Retrieved 2009-06-02. "A database for conopeptide sequences and structures"
Protein tertiary structure
|
|
General |
- Structural domain
- Protein folding
- Structure determination methods
|
|
All-α folds: |
- Helix bundle
- Globin fold
- Homeodomain fold
- Alpha solenoid
|
|
All-β folds: |
- Immunoglobulin domain
- Beta barrel
- Beta-propeller
|
|
α/β folds: |
- TIM barrel
- Leucine-rich repeat
- Flavodoxin fold
- Rossmann fold
- Thioredoxin fold
- Trefoil knot fold
|
|
α+β folds: |
- DNA clamp
- Ferredoxin fold
- Ribonuclease A
- SH2-like fold
|
|
Irregular folds: |
|
|
←Secondary structure
Quaternary structure→
|
|
- Toxins
- enterotoxin
- neurotoxin
- hemotoxin
- cardiotoxin
- phototoxin
|
|
Bacterial
toxins |
Exotoxin
|
Gram
positive
|
Bacilli
|
Clostridium:
|
- tetani
- Tetanospasmin
- Tetanolysin
- perfringens
- difficile
- botulinum
|
|
other:
|
- Anthrax toxin
- Listeriolysin O
|
|
|
Cocci
|
- Streptolysin
- Leukocidin
- Panton-Valentine leukocidin
|
|
Staphylococcus
|
- Staphylococcus aureus alpha/beta/delta
- Exfoliatin
- Toxic shock syndrome toxin
- Staphylococcal Enterotoxin B (SEB)
|
|
|
Actinobacteria
|
- Cord factor
- Diphtheria toxin
|
|
|
Gram
negative
|
- Shiga toxin
- Verotoxin/shiga-like toxin (E. coli)
- E. coli heat-stable enterotoxin/enterotoxin
- Cholera toxin
- Pertussis toxin
- Pseudomonas exotoxin
- Extracellular adenylate cyclase
|
|
Mechanisms
|
|
|
|
Endotoxin
|
- Lipopolysaccharide
- Bacillus thuringiensis delta endotoxin
|
|
Virulence
factor
|
- Clumping factor A
- Fibronectin binding protein A
|
|
|
Mycotoxins |
- Aflatoxin
- Amatoxin (alpha-amanitin, beta-amanitin,
- beta-Nitropropionic acid
- gamma-amanitin, epsilon-amanitin)
- Citrinin
- Cytochalasin
- Ergotamine
- Fumonisin (Fumonisin B1, Fumonisin B2)
- Gliotoxin
- Ibotenic acid
- Muscimol
- Ochratoxin
- Patulin
- Phalloidin
- Sterigmatocystin
- Trichothecene
- Vomitoxin
- Zeranol
- Zearalenone
|
|
Invertebrates |
scorpion:
|
- Androctonus australis hector insect toxin
- Charybdotoxin
- Maurotoxin
- Agitoxin
- Margatoxin
- Slotoxin
- Scyllatoxin
- Hefutoxin
- Lq2
- Birtoxin
- Bestoxin
- BmKAEP
- Phaiodotoxin
- Imperatoxin
|
|
spider:
|
- Latrotoxin
- CSTX
- Cupiennins
- PhTx3
- Stromatoxin
- Vanillotoxin
- Huwentoxin
|
|
mollusca:
|
- Conotoxin
- Eledoisin
- Onchidal
- Saxitoxin
- Tetrodotoxin
|
|
|
Vertebrates |
fish:
|
|
|
amphibian:
|
- (+)-Allopumiliotoxin 267A
- Batrachotoxin
- Bufotoxins
- Arenobufagin
- Bufotalin
- Bufotenin
- Cinobufagin
- Marinobufagin
- Epibatidine
- Histrionicotoxin
- Pumiliotoxin 251D
- Samandarin
- Samandaridine
- Tarichatoxin
|
|
reptile/snake venom:
|
- Bungarotoxin
- Alpha-Bungarotoxin
- Beta-Bungarotoxin
- Calciseptine
- Taicatoxin
- Calcicludine
- Cardiotoxin III
|
|
|
- note: some toxins are produced by lower species and pass through intermediate species
|
|
|
|
Cholinergics
|
|
Receptor ligands
|
|
mAChR
|
- Agonists: 77-LH-28-1
- AC-42
- AC-260,584
- Aceclidine
- Acetylcholine
- AF30
- AF150(S)
- AF267B
- AFDX-384
- Alvameline
- AQRA-741
- Arecoline
- Bethanechol
- Butyrylcholine
- Carbachol
- CDD-0034
- CDD-0078
- CDD-0097
- CDD-0098
- CDD-0102
- Cevimeline
- Choline
- cis-Dioxolane
- Ethoxysebacylcholine
- LY-593,039
- L-689,660
- LY-2,033,298
- McNA343
- Methacholine
- Milameline
- Muscarine
- NGX-267
- Ocvimeline
- Oxotremorine
- PD-151,832
- Pilocarpine
- RS86
- Sabcomeline
- SDZ 210-086
- Sebacylcholine
- Suberylcholine
- Talsaclidine
- Tazomeline
- Thiopilocarpine
- Vedaclidine
- VU-0029767
- VU-0090157
- VU-0152099
- VU-0152100
- VU-0238429
- WAY-132,983
- Xanomeline
- YM-796
Antagonists: 3-Quinuclidinyl Benzilate
- 4-DAMP
- Aclidinium Bromide
- Anisodamine
- Anisodine
- Atropine
- Atropine Methonitrate
- Benactyzine
- Benzatropine/Benztropine
- Benzydamine
- BIBN 99
- Biperiden
- Bornaprine
- CAR-226,086
- CAR-301,060
- CAR-302,196
- CAR-302,282
- CAR-302,368
- CAR-302,537
- CAR-302,668
- CS-27349
- Cyclobenzaprine
- Cyclopentolate
- Darifenacin
- DAU-5884
- Dimethindene
- Dexetimide
- DIBD
- Dicyclomine/Dicycloverine
- Ditran
- EA-3167
- EA-3443
- EA-3580
- EA-3834
- Etanautine
- Etybenzatropine/Ethylbenztropine
- Flavoxate
- Himbacine
- HL-031,120
- Ipratropium bromide
- J-104,129
- Hyoscyamine
- Mamba Toxin 3
- Mamba Toxin 7
- Mazaticol
- Mebeverine
- Methoctramine
- Metixene
- N-Ethyl-3-Piperidyl Benzilate
- N-Methyl-3-Piperidyl Benzilate
- Orphenadrine
- Otenzepad
- Oxybutynin
- PBID
- PD-102,807
- PD-0298029
- Phenglutarimide
- Phenyltoloxamine
- Pirenzepine
- Piroheptine
- Procyclidine
- Profenamine
- RU-47,213
- SCH-57,790
- SCH-72,788
- SCH-217,443
- Scopolamine/Hyoscine
- Solifenacin
- Telenzepine
- Tiotropium bromide
- Tolterodine
- Trihexyphenidyl
- Tripitamine
- Tropatepine
- Tropicamide
- WIN-2299
- Xanomeline
- Zamifenacin; Others: 1st Generation Antihistamines (Brompheniramine
- chlorphenamine
- cyproheptadine
- dimenhydrinate
- diphenhydramine
- doxylamine
- mepyramine/pyrilamine
- phenindamine
- pheniramine
- tripelennamine
- triprolidine, etc)
- Tricyclic Antidepressants (Amitriptyline
- doxepin
- trimipramine, etc)
- Tetracyclic Antidepressants (Amoxapine
- maprotiline, etc)
- Typical Antipsychotics (Chlorpromazine
- thioridazine, etc)
- Atypical Antipsychotics (Clozapine
- olanzapine, etc.)
|
|
nAChR
|
- Agonists: 5-HIAA
- A-84,543
- A-366,833
- A-582,941
- A-867,744
- ABT-202
- ABT-418
- ABT-560
- ABT-894
- Acetylcholine
- Altinicline
- Anabasine
- Anatoxin-a
- AR-R17779
- Butinoline
- Butyrylcholine
- Carbachol
- Choline
- Cotinine
- Cytisine
- Decamethonium
- Desformylflustrabromine
- Dianicline
- Dimethylphenylpiperazinium
- Epibatidine
- Epiboxidine
- Ethanol
- Ethoxysebacylcholine
- EVP-4473
- EVP-6124
- Galantamine
- GTS-21
- Ispronicline
- Lobeline
- MEM-63,908/RG-3487
- Nicotine
- NS-1738
- PHA-543,613
- PHA-709,829
- PNU-120,596
- PNU-282,987
- Pozanicline
- Rivanicline
- RJR-2429
- Sazetidine A
- Sebacylcholine
- SIB-1508Y
- SIB-1553A
- SSR-180,711
- Suberylcholine
- Suxamethonium/Succinylcholine
- TC-1698
- TC-1734
- TC-1827
- TC-2216
- TC-5214
- TC-5619
- TC-6683
- Tebanicline
- Tropisetron
- UB-165
- Varenicline
- WAY-317,538
- XY-4083
Antagonists: 18-Methoxycoronaridine
- α-Bungarotoxin
- α-Conotoxin
- Alcuronium
- Amantadine
- Anatruxonium
- Atracurium
- Bupropion
- Chandonium
- Chlorisondamine
- Cisatracurium
- Coclaurine
- Coronaridine
- Dacuronium
- Decamethonium
- Dextromethorphan
- Dextropropoxyphene
- Dextrorphan
- Diadonium
- DHβE
- Dimethyltubocurarine/Metocurine
- Dipyrandium
- Dizocilpine/MK-801
- Doxacurium
- Duador
- Esketamine
- Fazadinium
- Gallamine
- Hexafluronium
- Hexamethonium/Benzohexonium
- Ibogaine
- Isoflurane
- Ketamine
- Kynurenic acid
- Laudexium/Laudolissin
- Levacetylmethadol
- Malouetine
- Mecamylamine
- Memantine
- Methadone (Levomethadone)
- Methorphan/Racemethorphan
- Methyllycaconitine
- Metocurine
- Mivacurium
- Morphanol/Racemorphan
- Neramexane
- Nitrous Oxide
- Pancuronium
- Pempidine
- Pentamine
- Pentolinium
- Phencyclidine
- Pipecuronium
- Radafaxine
- Rapacuronium
- Rocuronium
- Surugatoxin
- Thiocolchicoside
- Toxiferine
- Trimethaphan
- Tropeinium
- Tubocurarine
- Vecuronium
- Xenon
|
|
|
|
Reuptake inhibitors
|
|
Plasmalemmal
|
CHT Inhibitors
|
- Hemicholinium-3/Hemicholine
- Triethylcholine
|
|
|
Vesicular
|
|
|
|
|
Enzyme inhibitors
|
|
Anabolism
|
ChAT inhibitors
|
- 1-(-Benzoylethyl)pyridinium
- 2-(α-Naphthoyl)ethyltrimethylammonium
- 3-Chloro-4-stillbazole
- 4-(1-Naphthylvinyl)pyridine
- Acetylseco hemicholinium-3
- Acryloylcholine
- AF64A
- B115
- BETA
- CM-54,903
- N,N-Dimethylaminoethylacrylate
- N,N-Dimethylaminoethylchloroacetate
|
|
|
Catabolism
|
AChE inhibitors
|
|
|
BChE inhibitors
|
- Cymserine * Many of the acetylcholinesterase inhibitors listed above act as butyrylcholinesterase inhibitors.
|
|
|
|
|
Others
|
|
Precursors
|
- Choline (Lecithin)
- Citicoline
- Cyprodenate
- Dimethylethanolamine
- Glycerophosphocholine
- Meclofenoxate/Centrophenoxine
- Phosphatidylcholine
- Phosphatidylethanolamine
- Phosphorylcholine
- Pirisudanol
|
|
Cofactors
|
- Acetic acid
- Acetylcarnitine
- Acetyl-coA
- Vitamin B5 (Pantethine
- Pantetheine
- Panthenol)
|
|
Others
|
- Acetylcholine releasing agents: α-Latrotoxin
- β-Bungarotoxin; Acetylcholine release inhibitors: Botulinum toxin (Botox); Acetylcholinesterase reactivators: Asoxime
- Obidoxime
- Pralidoxime
|
|
|
|
This article incorporates text from the public domain Pfam and InterPro IPR004214 This article incorporates text from the public domain Pfam and InterPro IPR008036